Drug
Actovegin clinical trials
How studies write it
Studies that test it under each name
Name
- Actovegin
- 2
Studies by the year they started
3 studies that test it; most in 2006 (1)
| Year | Studies |
|---|---|
| 2006 | 1 |
| 2012 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 3
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 3 · Other 0
Related medicines
As reviewed, each with the page that says it.
- One of Antioxidants source
- One of Central Nervous System Stimulants source
Studies
Open first, then newest update. How each study uses Actovegin is read from its arms, and is right about nine times in ten.
Testing it · 3
- Actovegin 12-Week Treatment Given First Intravenously and Subsequently Orally in Participants With Peripheral Arterial Occlusive Disease Fontaine Stage IIBCompletedPhase 3TakedaNCT03469349Written as Actovegin
- Efficacy and Safety of Actovegin in Post-stroke Cognitive Impairment (PSCI)CompletedPhase 3TakedaNCT01582854Written as Actovegin
- Actovegin® Versus Placebo in Patients With Diabetic Polyneuropathy (AV-007-IM)CompletedPhase 3NycomedNCT00483730Written as Deproteinised hemoderivative of calf blood (Actovegin)
Codes
What other systems call Actovegin · ClinicalTrials.gg INT002632
- MeSH (NLM) C015646ActoveginOne source ClinicalTrials.gov
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | C015646 | Actovegin | One source ClinicalTrials.gov |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.